These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8206187)

  • 1. [Cost of treatment using portable infusion pumps for subcutaneous insulin. State of the experiment in Lyon].
    Kressmann JB
    Diabete Metab; 1993 Dec; 19(5 Suppl):503-5. PubMed ID: 8206187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin pumps (portable pump for subcutaneous perfusion of insulin].
    Lassmann-Vague V; Guerci B; Hanaire-Broutin H; Leblanc H; Renard E; Thervet F; Vague P
    Diabete Metab; 1995 Dec; 21(5):371-7. PubMed ID: 8586155
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portable insulin infusion devices: a new era in the treatment of insulin-dependent diabetics! Which patients should be treated?
    Bruns W; Menzel R; Bibergeil H
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(4):227-34. PubMed ID: 6624175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation based cost-benefit analysis of a telemedical system for closed-loop insulin pump therapy of diabetes.
    Bott OJ; Hoffmann I; Bergmann J; Kosche P; von Ahn C; Mattfeld DC; Schnell O; Pretschner DP
    Stud Health Technol Inform; 2006; 124():435-40. PubMed ID: 17108558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion via portable pumps in ambulatory diabetics.
    Robins B; Bucholtz HK; Pelle A; D'Agostino M
    J Med Soc N J; 1982 Jun; 79(6):490-3. PubMed ID: 6956738
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pumps and other recent advances in the outpatient treatment of diabetes.
    Loewenstein JE
    Arch Intern Med; 1984 Apr; 144(4):755-8. PubMed ID: 6712374
    [No Abstract]   [Full Text] [Related]  

  • 13. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr.
    Palmer AJ; Roze S; Valentine WJ; Spinas G
    Diabet Med; 2004 Dec; 21(12):1372; author reply 1372-3. PubMed ID: 15569145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment with portable insulin pump for diabetics in 2002].
    Pinget M
    Journ Annu Diabetol Hotel Dieu; 2002; ():143-57. PubMed ID: 12525139
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pump therapy (continuous subcutaneous insulin infusion).
    White RD
    Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-infusion pumps in type I diabetes.
    Connell FA; Mitchell WH; Norman JE; McMahon P
    N Engl J Med; 1983 Jan; 308(2):100-1. PubMed ID: 6847930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug consumption in diabetes mellitus (V). Pharmacoeconomics and the acceptance of the hospital changeover to insulin U100. Group for the Study of Diabetes in Tarragona].
    Costa B; Estopá A; Borrás J; Sabaté A; Páez F
    Med Clin (Barc); 1996 Apr; 106(13):481-5. PubMed ID: 8992128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
    Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
    Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freedom machine: Canadian diabetics adapt to life on insulin-infusion pumps.
    Rolfe E
    Can Pharm J; 1982 Nov; 115(11):407-10. PubMed ID: 10257837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.